Cathepsin B-like Cysteine Proteases Confer Intestinal Cysteine Protease Activity in Haemonchus contortus*

Sankale ShompoleDagger and Douglas P. Jasmer

From the Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington 99164-7040

Received for publication, August 11, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cathepsin B-like cysteine protease genes (cbls) constitute large multigene families in parasitic and nonparasitic nematodes. Although expressed in the intestine of some nematodes, the biological and biochemical functions of the CBL proteins remain unresolved. Di- and tetra-oligopeptides were used as fluorogenic substrates and irreversible/competitive inhibitors to establish CBL functions in the intestine of the parasitic nematode Haemonchus contortus. Cysteine protease activity was detected against diverse substrates including the cathepsin B/L substrate FR, the caspase 1 substrate YVAD, the cathepsin B substrate RR, but not the CED-3 (caspase 3) substrate DEVD. The pH at which maximum activity was detected varied according to substrate and ranged from pH 5.0 to 7.0. Individual CBLs were affinity isolated using FA and YVAD substrates. pH influenced CBL affinity isolation in a substrate-specific manner that paralleled pH effects on individual substrates. N-terminal sequencing identified two isolated CBLs as H. contortus GCP-7 (33 kDa) and AC-4 (37 kDa). N termini of each began at a position consistent with proregion cleavage and protease activation. Isolation of the GCP-7 band by each peptide was preferentially inhibited when competed with a diazomethane-conjugated inhibitor, Z-FA-CHN2, demonstrating one functional difference among CBLs and among inhibitors. Substrate-based histological analysis placed CBLs on the intestinal microvilli. Data indicate that CBLs are responsible for cysteine protease activity described from H. contortus intestine. Results also support a role of CBLs in nutrient digestion.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cathepsin B-like cysteine protease (cbl)1 genes occur as large multigene families in a wide range of parasitic and free-living nematodes (1-3). The functions of CBL proteins remain unresolved at both a biochemical and biological level. Several cbl genes were shown to be expressed in the intestine of the parasitic worm Haemonchus contortus or in the free-living nematode Caenorhabditis elegans (1, 4). Accordingly, one function of nematode CBLs might be nutrient digestion.

CBLs may have application to control of parasitic nematodes in multiple ways. For instance, CBLs that function in host blood digestion are considered potential anthelmintic targets in schistosome flatworms (5, 6). CBLs are also currently considered as vaccine candidates for immune control of parasitic nematodes, including H. contortus (6-9). Alternatively, digestive proteases may indirectly mediate anthelmintic efficacy involving benzimidazole anthelmintics (10). Following fenbendazole treatment of lambs, anterior intestinal cells of H. contortus undergo fragmentation of nuclear DNA and tissue disintegration (10). The pattern of DNA fragmentation resembled that associated with apoptosis, which can be initiated by caspase and noncaspase cysteine proteases (11, 12), while CED-3 is a prominent nematode caspase (13). Both tissue disintegration and DNA fragmentation was associated with inhibited transport of secretory vesicles and subsequent cytoplasmic dispersal of vesicle contents in anterior intestinal cells (10). The monoclonal antibody (mAb 42/10.6.1) used to monitor secretory vesicle contents binds to a periodate-sensitive determinant found on numerous intestinal membrane and secretory proteins (14). Proteins that were immunoaffinity isolated by this mAb included an intestinal CBL, among other proteases (15). Therefore, CBLs might mediate some of the intestinal pathology induced by fenbendazole treatment.

Despite these connections with basic aspects of parasite biology, CBLs remain enigmatic. The complexity of the family (16) has hindered biochemical and functional characterization of CBLs. Intestinal CBLs have predicted signal peptides and are expected to be secreted. CBLs also have predicted proregions, and N termini of some isolated CBLs indicated propeptide cleavage (4, 16, 17). Cysteine protease activity was detected in H. contortus intestine and excretory-secretory products (ESP). This activity was characterized as cathepsin L-like, based on hydrolysis of Phe-Arg, but not Arg-Arg, dipeptide substrates (18). Glu245 was implicated in determining the ability of cathepsin B to degrade substrates with an Arg in the P2 position, a characteristic that is distinct from cathepsins L and S (16, 19). Most predicted CBL sequences from H. contortus lack a Glu corresponding to position 245 in cathepsin B (16), which theoretically could compromise the ability of H. contortus CBLs to hydrolyze Arg-Arg substrates.

This simple picture is complicated by several observations. In H. contortus ESP, distinct zymogram bands of cysteine protease activity were restricted to acidic pH, while others were active from acidic to neutral conditions (20). Phe-Arg substrate-based affinity probes identified four protease bands from ESP. This number was more restricted than expected according to the size of the CBL gene family reported. Substantial amino acid diversity was observed among CBL sequences at multiple positions within predicted S2 and S2' subsite residues, and then, between CBLs and cathepsin B (16, 19). Such diversity might translate into CBL properties that are distinct from related mammalian enzymes. Specific properties have not been attributed to any individual H. contortus CBL, which has hindered more directed research on recombinant forms of these enzymes.

In this study, H. contortus intestinal CBLs were directly linked to known cysteine protease activity from this worm. Substrates for known cathepsin L, cathepsin B, caspase 1, and CED-3 (caspase 3) enzymes proved effective for dissecting distinct CBL activities. The results provide guidance to investigate these CBLs in relation to normal biological functions, functional diversity among individual CBLs and CBL contributions to anthelmintic-induced intestinal pathology.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Fluorogenic peptide substrates included Ac-YVAD.AMC, Ac-DEVD.AMC, Z-FR.MNA, and Z-RR.MNA. Competitive peptide inhibitors included Ac-YVAD.CHO and Ac-DEVD.CHO. Irreversible peptide inhibitors included Z-FA.CHN2, Bt-YVAD.FMK, and Bt-FA.FMK. All of these substrates were obtained from Enzyme Systems Products (Dublin, CA).

Parasite and Extracts-- Approximately 10,000 viable L3 larvae of a Beltsville isolate of H. contortus (21) were used to orally infect 4-8-month-old parasite-free lambs, which were killed 25-27 days after infection. Adult worms were harvested for dissection of intestines and for culture to obtain ESP (20).

Protease Assays-- Intestines thawed from -80 °C were homogenized in PBS containing 1% Triton X-100. Protein concentration of lysates was determined by using the bicinchoninic acid protein assay reagent (Pierce). The extracts were stored in 200-µl aliquots at -80 °C. Protease activity was initially determined using the fluorogenic di- and tetrapeptide substrates, Z-FR.MNA, Z-RR.MNA, Ac-YVAD.AMC, and Ac-DEVD.AMC at 50 µM concentrations. Reactions were performed in 1.5-ml volumes with 10 µg of intestinal extracts or ESP and incubated at 37 °C for 2 h. Samples were evaluated at 30-min intervals for 2 h and activity reported for the 2-h incubations. Worm samples without substrates served as negative control. Inhibition studies incorporated protease-specific class inhibitors including 1 mM phenylmethylsulfonyl fluoride, 10 µM E-64, 100 µM leupeptin, 1 µM pepstatin, 100 µM iodoacetic acid, 10 mM 1,10-phenanthroline, or 5 mM EDTA. In addition, substrate-based dipeptide (Z-FA.CHN2) and tetrapeptide (Ac-YVAD.CHO, Ac-YVAD.FMK) protease inhibitors were used.

pH Profiles-- The pH activity profiles were established using the following buffers: 100 mM citrate phosphate (pH 3.0-7.0) or 100 mM phosphate (pH 8.0) and 50 mM glycine-NaOH (pH 9.0) containing 10 mM DTT. Classic caspase activity was evaluated under conditions of 10 mM DTT, 312.5 mM HEPES, 31.25% sucrose, 0.3125% CHAPS (pH 7.5). Liberation of the leaving fluorescent groups, AMC and MNA, was monitored with a fluorescence spectrophotometer (MPF 42A, Perkin Elmer Life Sciences) using excitation and emission wavelengths of 360 and 460 nm (AMC), respectively, or 340 and 425 nm (MNA), respectively. Specific activity was determined in picomoles of AMC or MNA liberated per minute per microgram of protein at 37 °C. A standard curve produced with free AMC or MNA was used for these measurements.

Affinity Isolation of Proteases-- Enzyme reactions were done by incubating 64 µg of intestinal extract with biotinylated irreversible substrate inhibitors Bt-YVAD.FMK or Bt-FA.FMK (5 µM) in 0.1 M citrate-phosphate buffer, pH 5.0, containing 10 mM DTT. The reaction mixtures were incubated for 15 min at 37 °C. Following this incubation, a mixture of protease inhibitors (100 µM leupeptin, 1 mM pepstatin, 10 mM 1,10-phenanthroline, and 10 µM E-64) was added to the solution. The mixture was adjusted to 0.2% SDS and incubated for an additional 15 min at room temperature with gentle agitation. This solution was used for affinity isolation procedures described below. Inhibition reactions were run by incubating the intestinal extracts with nonbiotinylated irreversible inhibitors, Ac-YVAD.FMK (5 µM), Z-FA.CHN2 (5 µM), or E-64 (10 µM) for 5 min (37 °C) prior to incubation with biotinylated substrate inhibitors.

Proteases conjugated to inhibitors were isolated by incubation with 100 µl of streptavidin-agarose beads (Sigma, St Louis, MO.) for 2 h at room temperature with gentle rotation. Bound beads were washed 5 times with 0.1 M glycine and 1% SDS (pH 8.0). The streptavidin-agarose beads were boiled in 3X-sample buffer for 15 min. Eluted proteins were fractionated on 7.5-17.5% gradient SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes as described previously (22). The membranes were blocked overnight at 4 °C in PBS, Tween 20 (0.1%), and nonfat dry milk (5%). Membranes were incubated with streptavidin-horseradish peroxidase conjugate (Kirkegaard & Perry Laboratories, Gaithersburg, MD) diluted 1:1000 in blocking buffer. Bound streptavidin was visualized using an enhanced chemiluminescence (ECL) detection system (Amersham Pharmacia Biotech, Amersham Place, United Kingdom). The Mr of stained proteins was estimated using prestained Rainbow molecular mass standards ranging from 14.3 to 200 kDa (Amersham Pharmacia Biotech).

Monoclonal Antibody 42/10.6.1-- This mAb (IgG2a) was used on immunoblots of affinity isolated proteases to evaluate glycosylation of CBLs and purity of the preparations. This mAb also provided enhanced sensitivity for evaluating affinity isolated proteins from ESP. Immunoblots were done with mAb 42/10.6.1 (2 µg/ml) as described (14). An isotype control mAb (Babb) against an irrelevant determinant was used as a control on replicate blots. Bound antibodies were detected with horseradish peroxidase-conjugated goat anti-mouse IgG diluted 1:3000 (Kirkegaard & Perry Laboratories). The blot was developed using ECL.

N-terminal Amino Acid Sequencing-- Proteases were isolated using Bt-YVAD.FMK (pH 5.0) or Bt-FA.FMK (pH 5.0 and 7.0). Affinity isolation procedures were optimized in standard assays by titrating the following components: peptide inhibitors, DTT, streptavidin-agarose beads, and the incubation time. Affinity isolation assays were then scaled up 50-fold to produce an estimated 450 pmol of proteins. Isolated proteases were fractionated on 7.5-17.5% gradient SDS-polyacrylamide gel electrophoresis and electroblotted onto polyvinylidene difluoride Immobilon-P membranes (Millipore, Bedford, MA). Transblotted proteins were visualized by staining with 0.1% Coomassie Blue for 10 min, followed by rapid destaining. Destained bands were excised and their N-terminal amino acid sequence determined using an Applied Biosystems 494/HT Procise sequencing system (University of Texas Medical Branch, Protein Chemistry Laboratory, Galveston, TX).

Cytolocalization of H. contortus Intestinal Proteases-- Location of H. contortus intestinal proteases was determined using the biotinylated peptide inhibitors Bt-YVAD.FMK and Bt-FA.FMK. Whole worms were placed in OCT compound (Tissue-TekR, Miles Inc., Elkhart, IN) and rapidly frozen in liquid nitrogen. Five micrometer tissue sections were cut using a cryotome, attached to ProbeOnTM Plus microscope slides (Fisher Scientific, Pittsburgh, PA), and air-dried for 30 min. Tissue sections were fixed in 30% methanol, 60% acetone, and 10% distilled H2O for 30 s at room temperature. Subsequently, the tissues were rinsed in PBS and incubated at 37 °C for 15 min in 0.1 M citrate-phosphate pH 5.0 buffer, 10 mM DTT, containing 5 µM Bt-YVAD.FMK or 5 µM Bt-FA.FMK. Inhibitor control tissue sections were pre-incubated with nonbiotinylated protease inhibitors or 5 µM E-64 for 15 min at 37 °C, followed by addition of biotinylated inhibitors. Negative control tissues were incubated without the peptides. The slides were then washed twice, for 5 min each, in wash buffer and blocked for 30 min at room temperature using PBS, Tween 20 (0.1%), and 10% normal sheep serum. Endogenous peroxidase inhibitor was included in reactions (Peroxidase Suppressor, ImmunoPureR; Pierce). Bound peptides were detected using streptavidin-horseradish peroxidase conjugate diluted 1:500 in blocking buffer. Streptavidin and biotin complexes were visualized using the ImmunoPure Metal Enhanced DAB (3,3'-diaminobenzidine tetrahydrochloride) substrate kit (Pierce).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Peptide Substrate Recognition in H. contortus Intestine and ESP-- Protease activity was evaluated in intestinal extracts and ESP using four peptide substrates with the following sequences (designations): FR (cathepsins B/L), RR (cathepsin B), YVAD (caspase 1), and DEVD (caspase 3/CED-3). Initial interest in evaluating caspase substrates arose from the DNA fragmentation that can be induced by fenbendazole in intestinal cell nuclei of this parasite (10). Preliminary experiments at pH 5.0 demonstrated activity against each substrate, with the exception of DEVD (Fig. 1). When further evaluated, optimal pH for activity varied according to the substrate used. For example, activity against the YVAD substrate was restricted predominately to acidic pH, while activity against the RR substrate was highest around pH 6.0, and relatively high activity against the FR substrate occurred from pH 4.5 to 7.5 (Fig. 2, A-C). No activity against the DEVD substrate was detected under any of the described pH conditions, including preferred caspase conditions (data not shown). Significant activity against the RR substrate was not expected in H. contortus intestine based on a previous report (18). In addition, the preferential activity against YVAD under acidic conditions is inconsistent for caspases, which have neutral pH requirements (11).



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   Protease activity in the intestines and ESP of adult H. contortus. Intestinal extracts (int) and ESP (10 µg) were assayed at pH 5.0 at 37 °C for 2 h. Fluorogenic substrates Z-FR.MNA, Z-RR-MNA, Ac-YVAD.AMC, and Ac-DEVD.AMC were used at 50 µM. Enzyme activity was expressed as picomoles of AMC/min/µg or picomoles of MNA/min/µg, respectively. Means of triplicate assays are presented, and bars represent standard deviations.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   pH effects on intestinal and ESP protease activity. Protease activities in intestinal extracts (int) and ESP of H. contortus were assayed at pH 3.0-9.0 with Z-FR.MNA (A), Z-RR.MNA (B), and Ac-YVAD.AMC (C). Means of triplicate assays are shown. Bars represent standard deviations.

Inhibitory effects of leupeptin and E-64 indicated that the majority of the activities against FR, RR, and YVAD substrates from intestine and ESP are due to cysteine proteases (Table I). Some variation on inhibition was observed among substrates with iodoacetic acid. Similar inhibitory results were obtained for FR and RR substrates at pH 5.0-6.0 (data not shown). Although 1,10-phenanthroline had moderate inhibitory effect on activities (57-87%), cysteine protease inhibition by 1,10-phenanthroline may be ascribed to a possible metal ion chelate. Although the relatively low inhibitory effect of EDTA supports this possibility, activity contributed by noncysteine proteases cannot be completely ruled out by these experiments. In contrast to the relative insensitivity of caspases to E-64 and leupeptin, intestinal activity against the YVAD substrate was ablated by both inhibitors. This result and observations on pH requirements suggested that activity against the YVAD substrate is conferred by noncaspase cysteine protease activity.


                              
View this table:
[in this window]
[in a new window]
 
Table I
Mean percentage of inhibition of protease activity from extracts of adult H. contortus intestine

Cross-inhibition of Protease Activity Using Peptide Substrates-- The possibility that related cysteine proteases confer activity against each of the substrates was evaluated by cross-inhibition experiments. Fluorogenic peptide substrates and peptide-based irreversible inhibitors were used in these experiments. Since no inhibitor construct was available for the RR substrate, experiments focused on the YVAD- and FR-based inhibitors. Additionally, a FA substrate modified by diazomethane (CHN2) was previously shown to inhibit H. contortus cysteine protease activity (20) and was used here. Activity against each substrate was inhibited at pH 5.0 by the irreversible inhibitors Ac-YVAD.FMK and Z-FA.CHN2 (Fig. 3). The inhibitor Ac-YVAD.CHO had similar effects on both YVAD and FR hydrolysis (data not shown). The high level of cross-inhibition suggested that a major portion of the activity against all substrates resided in the same enzymes at pH 5.0. 



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Substrate-based cross-inhibition of intestinal protease activities. Intestinal extracts (10 µg) were pre-incubated for 5 min with peptide substrate inhibitors Ac-YVAD.FMK or Z-FA.CHN2 (50 µM) at pH 5.0 and then incubated with fluorogenic substrates Ac-YVAD.AMC, Z-FR.MNA, or Z-RR.MNA at 37 °C for 2 h. Results were expressed as mean percentage of inhibition of activity compared with reactions with no inhibitors. Bars represent standard deviations of triplicate assays.

In contrast to YVAD, hydrolysis of the FR substrate was relatively high at pH 7.0. However, this activity was inhibited by Z-FA.CHN2 (92%), Ac-YVAD.FMK (94%), and Ac-YVAD.CHO (78%). This result suggests that pH 7.0 inhibited protease binding by YVAD to a much lesser extent than protease hydrolysis of this substrate, which will be discussed below. Nevertheless, the higher level of inhibition by the irreversible inhibitor Ac-YVAD.FMK compared with Ac-YVAD.CHO may indicate low level hydrolysis of this substrate at pH 7.0.

Affinity Isolation of Cysteine Proteases-- Biotinylated peptide substrates modified by a fluoromethylketone reactive group were used to isolate, characterize, and identify proteases that hydrolyze the peptide substrates described. Use of Bt-YVAD.FMK led to isolation of multiple prominent bands ranging from 29 to 37 kDa (Fig. 4A), with a 42-kDa band that was weakly visible (lane 2). A 33-kDa band was most prominent in multiple experiments. A similar profile of proteins was isolated by Bt-FA.FMK (lane 6), although the signal was always reduced compared with Bt-YVAD.FMK. A 33-kDa band was also most prominent in this lane, followed by a 37-kDa band. E-64 eliminated bands isolated by each of the biotinylated substrates, indicating they are cysteine proteases. Use of the nonbiotinylated inhibitor Ac-YVAD.FMK produced similar results. A Bt-DEVD.FMK probe failed to isolate any detectable bands from intestinal lysates (data not shown). The diazomethane inhibitor Z-FA.CHN2 was more discriminating, causing obvious reduction of only the 33-kDa band in preparations isolated by both the Bt-YVAD.FMK and Bt-FA.FMK. The two discernible weaker bands remaining at this position may reflect incomplete inhibition. Since Z-FA.CHN2 reduced activity against the FR and YVAD fluorogenic substrates by 100% and 94%, respectively (Fig. 3), proteases from the 33-kDa band may be largely responsible for hydrolyzing these substrates. Alternatively, Z-FA.CHN2 could function in fluorogenic assays as a competitive inhibitor against proteases that are otherwise resistant to irreversible binding by this inhibitor.



View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   Affinity isolation of H. contortus intestinal proteases with biotinylated peptide inhibitors. A, intestinal lysates (64 µg) were incubated without Bt-YVAD.FMK (lane 1), with Bt-YVAD.FMK (lanes 2-5), or with Bt-FA.FMK (lanes 6-9) at pH 5.0, affinity isolated, electrophoretically fractionated, and detected (see "Experimental Procedures"). Samples for competition inhibition assays were pre-incubated with nonbiotinylated peptide inhibitors identified below the panel. Arrows indicate two prominent bands identified at 33 and 37 kDa. B, immunoblot of intestinal proteins purified with Bt-YVAD.FMK (lane 1), purified with Bt-FA.FMK (lane 2), or from whole worm extracts (lane 3), using mAb 42/10.6.1 (2 µg/ml). Isolated proteins from 64 µg of extracts or 25 µg of whole intestine were used. No reactivity was observed on a replicate blot using an isotype control mAb (IgG2a). Arrows point to the 33- and 37-kDa proteases.

Monoclonal Antibody 42/10.6.1-- Previous results suggested that CBLs are modified by the periodate-sensitive determinant recognized by mAb 42/10.6.1 (16). This determinant occurs on a multitude of membrane/secreted/excreted proteins from H. contortus (14). Immunoblot analysis showed that most, if not all, proteins affinity-purified by Bt-YVAD.FMK and Bt-FA.FMK are modified by the mAb 42/10.6.1 determinant. In addition, the restricted size range of isolated proteins, compared with whole intestinal lysates, demonstrated a high level of purity in these preparations (Fig. 4B).

Substrate and pH-dependent Intestinal Protease Isolation-- pH effects were evaluated on affinity isolation at pH 5.0 and 7.0. The bands isolated by Bt-YVAD.FMK at pH 5.0 were eliminated at pH 7.0 (Fig. 5). In contrast, a similar profile of bands was isolated by Bt-FA.FMK regardless of the pH conditions used. These results are consistent with the pH effects on hydrolysis of fluorogenic substrates.



View larger version (41K):
[in this window]
[in a new window]
 
Fig. 5.   Differential pH effects on substrate binding. Intestinal lysates and ESP were reacted with Bt-YVAD.FMK (B-Y-F) at pH 5.0 or pH 7.0, or Bt-FA.FMK (B-F-F) as indicated. Isolated proteases were then detected with streptavidin-horseradish peroxidase (intestines) or by immunoblot methods with mAb 42/10.6.1 (ESP) as described for Fig. 4B.

Comparison of Affinity Isolated ESP and Intestinal Proteins-- Characteristics established for presumptive intestinal proteases were next applied to evaluate proteins in ESP. Streptavidin-horseradish peroxidase lacked necessary sensitivity for this purpose. Alternatively, mAb 42/10.6.1 provided for a sensitive detection method. A size range of proteins was isolated from ESP by each substrate that paralleled those found in intestine (Fig. 5). The proteins isolated behaved in a substrate- and pH-dependent manner that paralleled intestinal proteins. The results also establish that the isolated proteins are modified by the mAb determinant. Collectively, results agree with a previous report (18) that the ESP proteins most likely represent intestinal cysteine proteases excreted from the parasite.

Identification of CBLs from Affinity Isolated Proteins-- N-terminal sequencing was done on two isolated intestinal protein bands. The 33-kDa band was chosen based on evidence of activity against both YVAD and FR substrates. The 37-kDa band was chosen due to the relative resolution of this band and the resistance of the band to inhibition by Z-FA.CHN2. N-terminal sequences were obtained for bands isolated at pH 5.0 (FA, YVAD) and 7.0 (FA). Current data bases contain an estimated 11 published H. contortus CBL sequences (25) and expressed sequence tags for an additional 11 unique CBLs.2 The N-terminal sequences from each band had greatest similarity with H. contortus CBLs (Fig. 6). The sequences began at a uniform site consistent for pro-region cleavage, which is expected for the active proteases. Each sequence (20-24 residues) of the 37-kDa protein band isolated by each inhibitor, regardless of pH, exactly matched the H. contortus CBL AC-4 (Fig. 6). The residue corresponding to a single predicted cysteine residue was ambiguous in the protein sequences. The AC-4 sequence has multiple amino acids that are distinct from other CBLs, especially from consensus residues 11-17, providing a high degree of confidence in this identification.



View larger version (84K):
[in this window]
[in a new window]
 
Fig. 6.   Identification of affinity isolated proteases. N-terminal amino acid sequences (in bold) were obtained for affinity isolated protein bands (see "Experimental Procedures") and aligned with previously reported H. contortus cathepsin B-like cysteine protease sequences. Proteases were isolated with Bt-YVAD.FMK (yv) or Bt-FA.FMK (fa) at pH 5.0 (5) or pH 7.0 (7). The 33-kDa protease sequences were identical to GCP-7 (underlined) and the 37-kDa protease sequences were identical to AC-4 (underlined). fa7a and fa7b refer to a degenerate residue at the first position (D/E) for the 33-kDa band isolated by Bt-FA.FMK at pH 7.0. "X" represents an ambiguous amino acid predicted to be a cysteine residue in the sequences. P/A indicates the expected junction of the propeptide (P) cleavage site and active enzyme (A). Vertical bars at the bottom of the figure show the position of the AC-4 amino acids that are distinct from other CBLs. Numbers in parentheses refer to GenBank accession numbers: 1, A172357; 2, A1723422; 3, A11723514; 4, A1723554; 5, A1723598; 6, A1723446; 7, A1723444; 8, A1723442; 9, A1723407; 10, Z81327; 11, Z69346; 12, Z69344; 13, Z69345; 14, A1723403; 15, A1723612; 16, AF046229; 17, A1723380; 18, A1723416; 19, Z69342; 20, Z69343; 21, A1723392; 22, A1723405; 23, C48435; 24, M31112; 25, M34860; 26, D48435; 27, B48435.

Of the sequences from the 33-kDa band (10-17 residues), three exactly matched predicted amino acid sequence of the H. contortus CBL GCP-7 and an EST sequence (Hcgls1H4), which appears to represent GCP-7.2 These sequences were obtained from bands isolated by both the FA and YVAD affinity probes. The 33-kDa band obtained by FA isolation at pH 7.0 produced two alternative sequences due to heterogeneity (D/E) at the first residue (see fa7a and fa7b). The heterogeneity is likely to reflect more than one protease in this band. However, the dominant sequence clearly matches GCP-7 and the sequence is of sufficient length to instill a high degree of confidence in this identification.

Cytolocalization of Intestinal Proteases-- Cytolocalization of the intestinal CBLs identified was determined with the biotinylated peptide inhibitors. In parallel with affinity isolation results, Bt-YVAD.FMK proved more sensitive in histological assays than Bt-FA.FMK (Table II). In sections of whole worms, Bt-YVAD.FMK binding was found only at the microvillar surface of the worm intestine (Fig. 7A). E-64 completely inhibited substrate binding to microvilli (Fig. 7B). Some background peroxidase activity localized to intestinal cytoplasm (Fig. 7C), but did not extend to microvilli. In other experiments, Z-FA.CHN2 and Ac-YVAD.FMK completely inhibited binding of the biotinylated peptides to intestinal proteases in the H. contortus intestines (Table II). Experiments with Bt-FA.FMK produced weaker staining on microvilli that could be inhibited by E-64 and Z-FA.CHN2 (data not shown). From these results, we conclude that active intestinal CBLs localize to gut microvilli in vivo.


                              
View this table:
[in this window]
[in a new window]
 
Table II
Binding of di and tetrapeptide substrate probes to microvilli of H. contortus intestine at pH 5.0



View larger version (73K):
[in this window]
[in a new window]
 
Fig. 7.   Cytolocalization of H. contortus intestinal CBLs. Sections from frozen whole worms were incubated with Bt-YVAD.FMK (A, 5 µM), E-64 (5 µM) followed by Bt-YVAD.FMK (B), or no peptides (C). Biotinylated peptide binding was detected using streptavidin-conjugated horseradish peroxidase. White horizontal arrow, microvilli; black vertical arrow, reproductive organs; black horizontal arrows, body wall musculature.



    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Our results extend previous observations in which intestinal cysteine protease activity of H. contortus was shown to be capable of hydrolyzing a FR substrate (18). Those experiments also used affinity labeling with Bt-FA.FMK (18) to identify four protein bands (30, 34, 37, and 41 kDa) from ESP. We isolated intestinal proteases of similar size with the same reagent and showed that two of these proteins are CBLs with identity to H. contortus GCP-7 (33 kDa) and AC-4 (37 kDa). Specificity of these CBLs was extended to include the YVAD substrate. Although each band may contain multiple proteases, our results provide confidence in identification of the predominant CBLs in these bands. We anticipate that proteins isolated in other bands also represent distinct CBLs.

In contrast to previous results (18), significant activity was detected against a cathepsin B substrate (RR) that was inhibited by FA and YVAD inhibitor analogues. The result suggests that CBLs are responsible for this activity, also. Reasons for the discrepancy are unclear, since similar substrates and conditions were employed in both investigations. Our result is curious, since many H. contortus CBL sequences lack a glutamate corresponding to position 245 in cathepsin B, which is required for similar activity in cathepsin B (16, 24). However, the CBL HmCP6 has a glutamate at this position (7) and other unidentified CBLs might also. Further, we cannot exclude that different laboratory isolates of H. contortus vary in repertoire of CBLs and, hence, substrates recognized. Resolving these issues should be facilitated with the established connection between CBLs and intestinal cysteine protease activity in H. contortus.

Each of the CBLs identified exhibited diverse properties. Both the GCP-7 and AC-4 proteases bound to the FA and YVAD affinity probes under conditions of pH 5.0, demonstrating diverse substrate specificity. Likewise, both bound to the FA affinity probe at pH 7.0, demonstrating broad pH requirements. Other unidentified proteins that represent presumptive CBLs behaved similarly. Therefore, individual CBLs appear to possess labile properties that support activity against diverse substrates under a variety of pH conditions. Genes for the two CBLs identified (GCP-7 and AC-4) have been cloned (1, 15) and offer a means to investigate protease characteristics that determine these properties.

In contrast, failure to hydrolyze the DEVD substrate indicates one limit to CBL activity. In addition, pH requirements were more restricted for hydrolysis of the YVAD and RR substrates. For YVAD, inhibition of hydrolysis at pH 7.0 is not readily explained by inhibition of substrate binding, since YVAD substrate inhibitors abrogated activity against FR substrates at this pH. Therefore, inhibition of actual hydrolysis, not substrate binding, appears to explain these observations. Furthermore, CBLs isolated by both Bt-FA.FMK and Bt-YVAD.FMK appeared to be the same. This result indicates that hydrolysis of the YVAD substrate at pH 7.0 was inhibited in CBLs that otherwise had catalytic activity against the FR substrate. Therefore, this effect may reflect displacement of the YVAD substrate in the binding pocket due to a pH influence on the CBL or substrate. For instance, a pH-dependent specificity switch occurs in cruzain, a Trypanosoma cruzi cathepsin L-like enzyme that can bind both hydrophobic and basic residues at different pH environments (27). Insufficient information is currently available for comments regarding the protease. However, the P1 aspartate in YVAD is the most likely substrate residue to be altered in charge at pH 7.0, which may account for the inhibition observed. Caspase substrate inhibitors YVAD.FMK and VAD.FMK have been shown to inhibit cathepsin B (26), but parallel observations on pH-dependent substrate binding were not reported for this protease. Our results raise the possibility that protonation of the P1 aspartate is important for caspase substrate interactions with cathepsin B.

Regarding the significance of YVAD substrate hydrolysis, it may be important that acidic residues (aspartate or glutamate) immediately precede the predicted proregion cleavage site for HmCP6, AC-3, and AC-4. This position would represent the P1 site for CBLs. Since cathepsin B proregion cleavage is autocatalytic (28, 29), there may be a biological need for at least a subset of CBLs to hydrolyze substrates with P1 acidic residues.

In contrast to fluoromethyl ketone inhibitors, the diazomethane derivative of the FA substrate preferentially inhibited affinity isolation of the GCP-7 protease band. The fluoromethylketone derivative is more specific to active site cysteines than diazomethane (27). However, this property alone should not discriminate among individual proteases, whereas structural differences among CBLs might. CBL sequence diversity in nematodes has stimulated much speculation regarding the functional significance of this diversity (3, 4, 11, 16). The preferential inhibition of the GCP-7 band provides the first direct evidence of functional differences among H. contortus CBLs. AC-4 and GCP-7 sequences are quite divergent and were associated with distinct CBL clades from H. contortus (16). Notable differences in predicted S'2 binding sites distinguished members of these clades (16). In this context, differences such as that indicated by Z-FA.CHN2 are not unexpected. This discriminating property of the diazomethane inhibitor might have value for characterizing recombinant CBLs and dissecting CBL properties in vivo. Alternatively, this inhibitor would appear to have limitations for use as a general irreversible inhibitor of CBL functions in vivo.

One objective of the research was to establish definitions and approaches that would support research on CBLs in a biological context. For instance, CBLs have been immunolocalized to H. contortus microvilli (7, 8). Each of the affinity isolated CBLs evaluated had N termini consistent with pro-region cleavage and protease activation. Hence, CBLs detected on microvilli by affinity probes are most likely active enzymes. These and other results (7, 8, 18) support that CBLs have a major role in nutrient digestion by H. contortus. Further, 17% of expressed sequence tags from H. contortus intestine were cbl genes, which dominated all other intestinal genes/gene families found.2 These results indicate a prominent role for CBLs in the biology of H. contortus. In addition, fenbendazole treatment cause secreted intestinal proteins modified by the mAb 42/10.6.1 determinant to become dispersed in the cytoplasm of H. contortus intestinal cells that undergo degeneration (10). The dispersed proteins are likely to include CBLs, since CBLs are expressed in the intestine (7, 15, 16), are transported to microvilli (10), and, as shown here, are modified by the mAb 42/10.6.1 determinant. With the broad pH requirements observed, CBLs become potential candidates for mediating intestinal pathology induced by the anthelmintic fenbendazole. Finally, CBL activity can be distinguished from classic caspase activity, which may be important for elucidating cellular mechanisms of fenbendazole-induced DNA fragmentation (10).


    ACKNOWLEDGEMENTS

We appreciate the excellent technical support of Xiaoya Cheng and Stewart G. Bohnet in this work. Protein sequencing was done with support from the Protein Chemistry Laboratory at the University of Texas Medical Branch Educational Cancer Center (Galveston, TX) and the University of Texas Medical Branch NIEHS center grant.


    FOOTNOTES

* This work was supported by United States Department of Agriculture Grant NRICGP 98-35204-6461.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 509-335-6320; Fax: 509-335-8529; E-mail: shompole@vetmed.wsu.edu.

Published, JBC Papers in Press, October 13, 2000, DOI 10.1074/jbc.M007321200

2 S. Shompole and D. P. Jasmer, unpublished data.


    ABBREVIATIONS

The abbreviations used are: cbl and CBL, cathepsin B-like cysteine protease gene and protein, respectively; AMC, 7-amino-4-methylcoumarin; Ac-YVAD, acetyl-Tyr-Val-Ala-Asp; Ac-DEVD, acetyl-Asp-Glu-Val-Asp; CHO, aldehyde; MNA, 4-methoxy-2-naphthalamine; Z-FR, benzyloxycarbonyl-Phe-Arg; Z-RR, benzyloxycarbonyl-Arg-Arg; CHN2, diazomethane; Bt, biotin; FMK, fluoromethyl ketone; E-64, trans-epoxysuccinyl-L-leucylamide-(4-guanidino)-butane; ESP, excretory and secretory products; DTT, dithiothreitol; PBS, phosphate-buffered saline; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; mAb, monoclonal antibody.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Pratt, D., Armes, L. G., Hageman, R., Reynolds, V., Boisvenue, R. J., and Cox, G. N. (1992) Mol. Biochem. Parasitol. 51, 209-218[Medline] [Order article via Infotrieve]
2. Harrop, S. A., Prociv, P., and Brindley, P. J. (1995) Trop. Med. Parasitol. 46, 119-122[Medline] [Order article via Infotrieve]
3. Waterston, R., Martin, C., Craxton, M., Huynh, C., Coulson, A., Hillier, L., Durbin, R., Green, P., Shownkeen, R., Halloran, N., Metzstein, M., Hawkins, T., Wilson, R., Berks, M., Du, Z., Thomas, K., Thierrymieg, J., and Sulston, J. (1992) Nat. Genet. 1, 114-123[Medline] [Order article via Infotrieve]
4. Larminie, C. G., and Johnstone, I. L. (1996) DNA Cell Biol. 15, 75-82[Medline] [Order article via Infotrieve]
5. Brindley, P. J., Kalinna, B. H., Dalton, J. P., Day, S. R., Wong, J. Y., Smythe, M. L., and McManus, D. P. (1997) Mol. Biochem. Parasitol. 89, 1-9[CrossRef][Medline] [Order article via Infotrieve]
6. Wasilewski, M. M., Lim, K. C., Phillips, J., and McKerrow, J. H. (1996) Mol. Biochem. Parasitol. 81, 179-189[CrossRef][Medline] [Order article via Infotrieve]
7. Skuce, P. J., Redmond, D. L., Liddell, S., Stewart, E. M., Newlands, G. F., Smith, W. D., and Knox, D. P. (1999) Parasitology 119, 405-412[CrossRef][Medline] [Order article via Infotrieve]
8. Knox, D. P., Smith, S. K, and Smith, W. D. (1999) Parasite Immunol. 21, 201-10[CrossRef][Medline] [Order article via Infotrieve]
9. Smith, S. K., Pettit, D., Newlands, G. F. J., Redmond, D. L., Skuce, P. J., Knox, D. P., and Smith, W. D. (1999) Parasite Immunol. 21, 187-199[CrossRef][Medline] [Order article via Infotrieve]
10. Jasmer, D. P., Yao, C., Rehman, A., and Johnson, S. (2000) Mol. Biochem. Parasitol. 105, 81-90[CrossRef][Medline] [Order article via Infotrieve]
11. Alnemri, E. S. (1997) J. Cell. Biochem. 64, 33-42[CrossRef][Medline] [Order article via Infotrieve]
12. Vaux, D. L., Wilhelm, S., and Hacker, G. (1997) Mol. Cell. Biol. 17, 6502-6507[Abstract]
13. Xue, D., Shaham, S., and Horvitz, H. R. (1996) Genes Dev. 10, 1073-1083[Abstract]
14. Jasmer, J. P., Perryman, L. E., Conder, G. A., Crow, S., and McGuire, T. C. (1993) J. Immunol. 151, 5450-5460[Abstract/Free Full Text]
15. Rehman, A., and Jasmer, D. P. (1998) Mol. Biochem. Parasitol. 97, 55-68[CrossRef][Medline] [Order article via Infotrieve]
16. Rehman, A., and Jasmer, D. P. (1999) Mol. Biochem. Parasitol. 102, 297-310[CrossRef][Medline] [Order article via Infotrieve]
17. Cox, G. N., Pratt, D., Hageman, R., and Boisvenue, R. J. (1990) Mol. Biochem. Parasitol. 41, 25-34[Medline] [Order article via Infotrieve]
18. Rhoads, M. L., and Fetterer, R. H. (1995) J. Parasitol. 81, 505-512[Medline] [Order article via Infotrieve]
19. Musil, D., Zucic, D., Turk, D., et al.. (1991) EMBO J. 10, 2321-2330[Abstract]
20. Karanu, F. N., Rurangirwa, F. R., McGuire, T. C., and Jasmer, D. P. (1993) Exp. Parasitol. 77, 362-371[CrossRef][Medline] [Order article via Infotrieve]
21. Jasmer, D. P., and McGuire, T. C. (1991) Infect. Immun. 59, 4412[Medline] [Order article via Infotrieve]
22. Towbin, H., and Gordon, H. (1984) J. Immunol. Methods 72, 313-340[CrossRef][Medline] [Order article via Infotrieve]
23. Hughes, A. L. (1994) Mol. Phylogenet. Evol. 3, 310-321[CrossRef][Medline] [Order article via Infotrieve]
24. Hasnain, S., Hirama, T., Huber, C. B., Mason, P., and Mort, J. S. (1993) J. Biol. Chem. 268, 235-240[Abstract/Free Full Text]
25. Schotte, P., Declercq, W., Huffel, S., Vandenabeele, P., and Beyaert, R. (1999) FEBS Lett. 442, 117-121[CrossRef][Medline] [Order article via Infotrieve]
26. Shaw, E., Angliker, H., Rauber, P., Walker, B., and Wikstrom, P. (1986) Biomed. Biochim. Acta 45, 1397-1403[Medline] [Order article via Infotrieve]
27. Gilmor, S. A., Craik, C. S., and Fletterick, R. J. (1997) Protein Sci. 6, 1603-1611[Abstract/Free Full Text]
28. Hasnain, S., Hirama, T., Tam, A., and Mort, J. S. (1992) J. Biol. Chem. 267, 4713-4721[Abstract/Free Full Text]
29. Fox, T., Miguel, E., Mort, J. S., and Storer, A. C. (1992) Biochemistry 31, 12571-12576[Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.